RxDoctor Payments Data

Jessica Krueger

Nurse Practitioner · Las Cruces, NMNPI 1619516325

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $974 and has fallen 74.4% since, to $250 in 2025. Among nurse practitioner clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,888in general payments, 2019–2025

Across 89 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$307
  • AbbVie$298
  • Lilly USA, LLC$249
  • Esperion Therapeutics, Inc.$147
  • Johnson & Johnson$142
  • AstraZeneca$94
  • plus $650 from 19 others

What the payments were for

  • Food & beverage$1,888100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,888 in reported general payments places this provider in the 90th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$16,327
MounjaroTirzepatide14$14,240
Celecoxib11$563
Gabapentin29$488
Ezetimibe13$472
Omeprazole26$403
Rosuvastatin Calcium29$390
Duloxetine Hcl16$311
Levothyroxine Sodium27$284
Venlafaxine Hcl ErVenlafaxine Hcl11$247
Amlodipine Besylate37$240
Fluticasone Propionate18$228
Losartan Potassium19$213
Metformin Hcl20$207
Lisinopril33$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$249$14,24014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 624 nurse practitioner providers in New Mexico.

Other nurse practitioner in Las Cruces

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →